EPR Healthcare News

Medicines for Malaria Venture (MMV) Joins The Pool for Open Innovation Against Neglected Tropical Diseases

Global Health Progress (GHP) is pleased to highlight the announcement that the not-for-profit public-private partnership Medicines for Malaria Venture (MMV) will became the first product development partnership (PDP) to contribute intellectual property to The Pool for Open Innovation against Neglected Tropical Diseases (The Pool). MMV joined GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and ...

Global Health Progress Stresses Importance of Product Development Partnerships

Helen Coster’s recent commentary in her new Forbes blog Good Work addresses the issue of how product development partnerships (PDPs) can develop and improve treatments for neglected diseases like malaria, leishmaniasis, and Chagas disease. Coster notes, “These diseases affect the world’s poorest people, and they often get ignored by pharmaceutical companies ...

Top Government Hospital for Stem Cell Treatments and Research Located in Beijing Launches English Website

The Stem Cell Transplantation Department at the General Hospital of Chinese People's Armed Police Forces has launched an English version of its website www.sinostemcells.com for its ever-growing international patients seeking Stem cell treatments. The new user-friendly site reflects the department's vision of readily available, authentic, and relevant information and aims to supply ...

Recent African Leaders Malaria Alliance Meeting Highlights Importance of Partnerships to Ensure Continued Progress on Malaria Vaccine

During the recent African Union summit, the African Leaders Malaria Alliance (ALMA) gathered to discuss how to combat the threat of malaria in the continent. Inspired by this meeting, Madiké Seye, Vice-President for Africa – GlaxoSmithKline wrote a guest article on the Independent's website calling for “new tools, such as ...

Global Health Progress Epitomizes Clinton, Gates’ Call for ‘Efficiency Savings’ In Regards to HIV/AIDS Prevention Treatments, Services

During a recent international conference in Vienna for 20,000 AIDS scientists, health workers and activists, former U.S. President Bill Clinton and Microsoft founder Bill Gates urged AIDS activists to try to generate the most value possible out of funds set aside for HIV/AIDS prevention services and treatments, including securing access ...

Global Health Progress Highlights ViiV Healthcare’s Announcement of New Initiatives

Global Health Progress highlights ViiV Healthcare’s announcement of a new series of initiatives, including improving access to medicines, to support people living with HIV/AIDS in the poorest and most vulnerable countries. To address the evolving treatment needs in these countries, ViiV Healthcare will now allow people living with HIV/AIDS to access ...

Global Health Progress Releases New Report that Features Innovative Solutions to Improve Access to Healthcare in India

Global Health Progress’ recently released report, Innovative Solutions to Improving Health in India, summarizes how the organization is committed to building sustainable, innovative solutions to secure access to healthcare for all Indian communities. The report notes that access to healthcare remains problematic in parts of India, especially in rural areas. For ...

UIC Master of Science in Health Informatics: First in the Nation to Receive Prestigious CAHIIM Accreditation

The University of Illinois at Chicago (UIC) is pleased to announce that the Commission on Accreditation for Health Informatics and Information Management Education (CAHIIM) has accredited its online Master of Science degree in Health Informatics. The UIC program is the first master level degree program to receive CAHIIM accreditation. Prior ...

Unitaids Pool for HIV/AIDS Pharmaceutical Patents Appears Flawed

Recently the International Policy Network (IPN), a nongovernmental educational organization focused on highlighting the role of free society institutions in social and economic development, released a report discussing Unitaid’s proposed pharmaceutical patent pool. Written by Alec van Gelder and Philip Stevens, this report examines the implications of creating a pharmaceutical ...

Pharmacy College Teacher And Students Write On A Common Blog To Share Quickly Pharmaceutical Industry Technology Developments

Dr.Martin a former teacher in pharmacy college and now a director in a worlds biggest pharmaceutical company, was favorite amongst his students and colleagues for his innovative ideas on research and development teaching subjects on pharmaceutical and biotechnology. One day he and his students on their last day in the college ...

Health Analytics, LLC Announces new Contract with Medtronic

Health Analytics, LLC announces today that it has signed a agreement with Medtronic to provide a study for Obstructive Sleep Apnea. The study will examine the effects of the Repose™ System. Health Analytics a healthcare intelligence firm that conducts and interprets scientific studies to improve healthcare outcomes, provide valuable business insights, ...

NAICONS and NexThera Transfer Rights Of NAI-107, A New Anti-MRSA Antibiotic, To Sentinella Pharmaceuticals

NAICONS (New Anti-Infectives CONSortium) and NexThera Biosciences, Italian companies focusing on the discovery and development of novel anti-infective drugs, today announced that they have entered into an agreement with Sentinella Pharmaceuticals, Inc., a US-based pharmaceutical company established by Care Capital LLC, a leading life sciences venture capital firm. Under the terms ...

Catalent Expands Capabilities In Testing For Melamine In Food And Medicinal Products

At a time when melamine-contamination has received global attention, Catalent Pharma Solutions continues its legacy of innovation by rapidly developing new FDA guidance-compliant tests for trace amounts of key contaminants in food and medicine. Incidents of melamine contamination in milk products, baby formula, dairy and non-dairy products manufactured in China ...

Catalent To Present Webinar On Stabilities Studies In Pharmaceutical Development

Catalent Pharma Solutions will host a free Webinar featuring Senior Manager, Wei Pan, Ph.D. RAC and Kathy Waddle, Director, Stability QC Biology. The one-hour Webinar will cover stability studies as a critical part of the drug development process and the vital role they play for drug product marketing approval. The ...

Senior Director of Biotechnology at Catalent To Present Industry Conferences

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be delivering workshops this October at two industry conferences. The first will be a pre-conference workshop at Cambridge Health Institute’s Immunogenicity Summit. The event will take place in Philadelphia on Monday, October 26, 2009. The interactive workshop, titled ...

The World’s First Dry-On-Contact H1N1 Sanitising Spray

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States.. After patenting the product he was awarded EPA registration for its ...

Three Alternative Scenarios of the Future In Vitro Diagnostics Market, 2009-2018

Venture Planning Group is pleased to announce completion of the new multiclient study, “Three Alternative Scenarios of the Future In Vitro Diagnostics Market, 2009-2018." The report is designed to assist executives in the diagnostics industry in formulating policy alternatives that will provide the best choice among possible courses of action. The ...

Dr. Hans Westenburg, A Senior Scientist At Catalent Pharma Solutions, Will Present At The TIDES 2009 Conference

Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009. The conference agenda was put together by leaders in oligonucleotide and peptide development and manufacturing, and ...

Jenken Biosciences Granted Key Patent for Compounds To Treat Chronic Liver and Kidney Diseases

Jenken Biosciences, Inc., an emerging specialty pharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent on Jenken’s compounds for the treatment of diseases associated with kidney diseases and chronic liver diseases, such as hepatitis and fatty liver disease. Jenken’s patented compounds are developed ...

Catalent Analytical Team Member to be Published in Journal of Pharmaceutical Research

Catalent Pharma Solutions, a worldwide leading provider of advanced technologies for pharmaceutical, biotechnology and consumer health companies, will be featured in the upcoming April edition of Journal of Pharmaceutical Research. Stephen P. Mayock, a member of Catalent’s analytical team, was a major contributor to the article that conveys the present ...

The Harley Medical Group Reports In Increase In Bald Patch Treatments

The Harley Medical Group has reported demand from male patients for laser rejuvenation treatments is up +93% over the last quarter, across its 30 clinics. Laser rejuvenation treatments now account for 11% of all non-surgical treatments carried out during June, July and August at the UK’s largest cosmetic surgery group. More ...

Medicines for Malaria Venture (MMV) Joins The Pool for Open Innovation Against Neglected Tropical Diseases

Global Health Progress (GHP) is pleased to highlight the announcement that the not-for-profit public-private partnership Medicines for Malaria Venture (MMV) will became the first product development partnership (PDP) to contribute intellectual property to The Pool for Open Innovation against Neglected Tropical Diseases (The Pool). MMV joined GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and ...

Search

The archives run deep. Feel free to search older content using topic keywords.